
Formation Bio is a tech and AI driven pharma company differentiated by radically more efficient drug development.
Advancements in AI and drug discovery are creating more candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as TrialSpark Inc., has built technology platforms, processes, and capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs from pharma companies, research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by investors across pharma and tech, including a16z, Sequoia, Sanofi, Thrive Capital, Sam Altman, John Doerr, Spark Capital, SV Angel Growth, and others.
You can read more at the following links:
At Formation Bio, our values are the driving force behind our mission to revolutionize the pharma industry. Every team and individual at the company shares these same values, and every team and individual plays a key part in our mission to bring new treatments to patients faster and more efficiently.
About the Position
Formation Bio is looking for a Senior Manager to join its Brand & Communications team, reporting directly to the Head of Brand & Communications. This is a broad, high-ownership role for someone who wants to work across the full scope of a modern brand and communications function — internal comms, external brand initiatives, events, drug program communications, and brand operations — at a company doing something genuinely new in the world and therefore with a brand new story to tell.
To succeed, you must have a track record of excellent taste, pristine execution, seamless coordination, and operational excellence. You will own several workstreams end-to-end and support others, serving as a reliable, high-judgment partner to the Head of Brand & Communications across everything the function touches.
We're looking for someone who is extremely plugged into the tech and AI conversation, who instinctively understands how ideas travel, what's resonating, and where Formation Bio should show up. You bring intense enthusiasm for AI innovation and automation, and believe communications can be deeply human while leveraging AI to drive efficiency and scale. You'll be instrumental in helping build an AI-native communications function that fits squarely into Formation's broader mission and culture.
Responsibilities
Internal Communications
Brand Initiatives
Brand Operations
About You
Formation Bio is prioritizing hiring in key hubs, primarily the New York City and Boston metro areas. These positions will follow a hybrid work model with 1-3 days required at the office. Applicants from the Research Triangle (NC) and San Francisco Bay Area may also be considered. Please only apply if you reside in these locations or are willing to relocate.
Compensation Range: $154,500 - $202,000
Salary ranges are informed by a number of factors including geographic location. The range provided includes base salary only. In addition to base salary, we offer equity, comprehensive benefits, generous perks, hybrid flexibility, and more. If this range doesn't match your expectations, please still apply because we may have something else for you.
You will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.

Formation Bio is an AI-native pharma company differentiated by radically more efficient drug development. The company has built proprietary technology platforms to optimize critical aspects of clinical drug development, enabling more efficient trial design, faster trial completion, and higher quality trial data. Formation Bio acquires clinical-stage drugs from pharmaceutical and biotech companies with the goal to develop assets faster, unlocking greater value per program and ultimately accelerate access to new treatments for patients.
2025 CNBC Disruptor 50
2025 Fierce 15 Award
2024 Endpoints 11 Award